Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía Adrián, Silvia
dc.contributor.authorNeria Serrano, Fernando
dc.contributor.authorMuñoz Martín, Andrés J.
dc.date.accessioned2023-03-31T11:57:04Z
dc.date.available2023-03-31T11:57:04Z
dc.date.issued2022
dc.identifier.issn0953-6205spa
dc.identifier.urihttps://hdl.handle.net/10641/3319
dc.description.abstractBackground Pancreatic carcinoma is one of the tumors associated with a higher risk for thromboembolic events, with incidence rates ranging from 5% to 41% in previous retrospective series. Patients and methods We conducted a retrospective study in eleven Spanish hospitals that included 666 patients diagnosed with pancreatic carcinoma (any stage) between 2008 and 2011 and treated with chemotherapy. The main objective was to evaluate the incidence of venous thromboembolic events (VTE) in this population, as well as potential risk factors for thrombosis. The impact of VTE on mortality was also assessed. Results With a median follow-up of 9.3 months, the incidence of VTE was 22.1%; 52% were diagnosed incidentally. Our study was unable to confirm the ability of the Khorana score to discriminate between patients in the intermediate or high risk category for thrombosis. The presence of VTE proved to be an independent prognostic factor associated with increased risk of death (HR 2.39, 95% CI 1.96–2.92). Symptomatic events correlated with higher mortality than asymptomatic events (HR 1.72; 95% CI, 1.21–2.45; p = 0.002), but incidental VTE, including visceral vein thrombosis (VVT), negatively affected survival compared to patients without VTE. Subjects who developed VTE within the first 3 months of diagnosis of pancreatic carcinoma had lower survival rates than those with VTE after 3 months (HR 1.92, 95% CI 1.30–2.84; p<0.001). Conclusions Pancreatic carcinoma is associated with a high incidence of VTE, which, when present, correlates with worse survival, even when thrombosis is incidental. Early onset VTE has a particularly negative impact.spa
dc.language.isoengspa
dc.publisherEuropean Journal of Internal Medicinespa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectPancreatic carcinomaspa
dc.subjectVenous thrombosisspa
dc.subjectIncidencespa
dc.subjectKhorana scorespa
dc.titleIncidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent1290 KBspa
dc.identifier.doi10.1016/j.ejim.2022.07.020spa
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0953620522002692?via%3Dihubspa


Ficheros en el ítem

FicherosTamañoFormatoVer
PIIS0953620522002692.pdf1.259MbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España